The nation of Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over Washington's demand for sensitive information.
The decision became public after a government memo dated December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "lopsided".
A government representative has since clarified that the US was seeking health data for research and profit while was unwilling to share the benefits from future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued negotiations to reach a agreement acceptable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were filed about the safety of citizens' medical information.
Since resuming office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
Based on reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"Effectively, our country would supply the basic resources for medical research without any certainty that the end products would be accessible to our people if a future pandemic arise."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining systems previously set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This framework is designed to guarantee that when a nation provides its information, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation could be designed in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body expressed it recognised the government's concerns, but suggested that talks need to persist given that much of the country's Aids initiatives relied on international support.
"If technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
This impasse underscores the continuing challenges between receiving crucial international aid and protecting a country's data in an ever more interconnected world.